+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Contract Pharmaceutical Manufacturing global market

Contract Pharmaceutical Manufacturing global market

Contract Pharmaceutical Manufacturing Global Market Research 2026

Contract Pharmaceutical Manufacturing Global Market Research 2026 market report providing analysis of industry trends, market dynamics, regional insights, competitive landscape, and growth forecast.

Pages: 220

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Contract Pharmaceutical Manufacturing Market

Market Overview

The global Contract Pharmaceutical Manufacturing market plays a pivotal role in the modern pharmaceutical value chain. Contract Pharmaceutical Manufacturing Organizations (CPMOs) provide outsourced services to pharmaceutical and biotechnology companies, covering Active Pharmaceutical Ingredient (API) manufacturing, Finished Dosage Form (FDF) production, formulation development, packaging, and related support services.

This outsourcing model allows pharmaceutical companies to reduce capital expenditure, accelerate time-to-market, manage regulatory complexity, and focus internal resources on core competencies such as drug discovery, marketing, and commercialization.

The industry is characterized by low to moderate market concentration, with the top eighteen manufacturers collectively accounting for approximately 22% of global revenue, indicating a competitive and fragmented landscape.

Market Size and Growth Outlook

  • Base Year: 2025
  • Historical Period: 2020–2024
  • Forecast Period: 2026–2036

The global Contract Pharmaceutical Manufacturing market is valued at US$ 68,700 million in 2025 and is projected to reach US$ 108,800 million by 2036, expanding at a CAGR of 5.9% during the forecast period.

Sustained growth is supported by increasing pharmaceutical R&D activity, patent expirations, rising generic drug production, and growing biologics and specialty drug pipelines.

Industry Structure and Characteristics

  • Fragmented market with a mix of large multinational CPMOs and regional specialists
  • Strong regulatory oversight and high compliance requirements
  • Long-term contractual relationships between pharmaceutical sponsors and manufacturers
  • Increasing trend toward integrated end-to-end manufacturing services

Market Segmentation

By Product Type

1. Active Pharmaceutical Ingredients (API)

  • Small molecule APIs
  • High-potency APIs (HPAPI)
  • Specialty and complex chemical APIs
    API manufacturing represents a significant revenue share due to high technical complexity, regulatory burden, and increasing outsourcing by innovator and generic companies.

2. Finished Dosage Form (FDF)

  • Solid oral dosage forms
  • Injectables
  • Semi-solids and liquids
    FDF outsourcing is expanding rapidly, driven by demand for scalable production, sterile manufacturing capabilities, and lifecycle management services.

By Application

  • Big Pharma
    Focus on large-scale production, global supply reliability, and regulatory compliance
  • Generics
    High-volume, cost-efficient manufacturing with rapid market entry requirements
  • Specialty and Mid-sized Pharmaceutical Companies
    Outsourcing driven by limited internal manufacturing infrastructure
  • Other Applications
    Includes biotech firms, virtual pharma companies, and contract development projects

Key Market Players

  • Catalent
  • DPx
  • Lonza
  • Piramal Healthcare
  • Aenova
  • Jubilant
  • Famar
  • Boehringer Ingelheim
  • Fareva Holding
  • AbbVie
  • Nipro Corp
  • Vetter
  • Sopharma
  • DPT Laboratories
  • Recipharm
  • NextPharma
  • Dishman
  • Aesica

Competitive strategies include capacity expansion, geographic diversification, biologics capability enhancement, and mergers and acquisitions.

Regional Analysis

North America

North America is the largest regional market, driven by a strong pharmaceutical ecosystem, advanced manufacturing capabilities, and high outsourcing adoption. The United States dominates regional demand, supported by large innovator companies and a growing biologics pipeline.

Europe

Europe represents a mature and technologically advanced market. Countries such as Germany, France, the UK, and Italy benefit from strong regulatory frameworks and established CDMO infrastructure. Europe remains a preferred region for high-quality and complex pharmaceutical manufacturing.

Asia-Pacific

Asia-Pacific is the fastest-growing region, supported by cost advantages, expanding pharmaceutical exports, and improving regulatory compliance.

  • India is a global hub for API and generic drug manufacturing
  • China is rapidly expanding capacity in APIs and intermediates
  • Japan focuses on high-quality and specialty manufacturing

Central & South America

Growth is moderate and primarily driven by Brazil and Argentina. The region benefits from increasing local pharmaceutical demand and gradual outsourcing adoption.

Middle East & Africa

This region represents an emerging opportunity, supported by government initiatives to localize pharmaceutical manufacturing and reduce import dependency.

Competitive Landscape

Porter’s Five Forces Analysis

  • Threat of New Entrants: Low to Moderate
    High capital investment, regulatory barriers, and quality requirements limit entry
  • Bargaining Power of Suppliers: Moderate
    Specialized raw material suppliers maintain some leverage
  • Bargaining Power of Buyers: High
    Large pharmaceutical companies exert strong pricing and quality pressure
  • Threat of Substitutes: Low
    In-house manufacturing is capital-intensive and less flexible
  • Competitive Rivalry: High
    Fragmented market with strong competition on cost, quality, and service breadth

SWOT Analysis

Strengths

  • Regulatory expertise and compliance capabilities
  • Cost efficiency and scalability
  • Global manufacturing footprint

Weaknesses

  • Margin pressure due to pricing competition
  • Dependence on long-term contracts

Opportunities

  • Growth in biologics and specialty drugs
  • Rising outsourcing by virtual pharma companies
  • Emerging market pharmaceutical expansion

Threats

  • Regulatory non-compliance risks
  • Supply chain disruptions
  • Increasing quality expectations

Trend Analysis

  • Shift toward end-to-end CDMO services
  • Increasing biologics and sterile manufacturing outsourcing
  • Strategic capacity expansions in Asia-Pacific
  • Growing focus on quality-by-design (QbD) and digital manufacturing

Drivers and Challenges

Key Drivers

  • Rising pharmaceutical R&D expenditure
  • Patent expirations and generic drug growth
  • Cost and risk reduction through outsourcing
  • Increasing regulatory complexity

Key Challenges

  • Regulatory compliance and inspection risks
  • Talent shortages in advanced manufacturing
  • Pricing pressure from large pharma clients

Value Chain Analysis

  1. Raw Material and Intermediate Suppliers
  2. API Manufacturing
  3. Formulation and FDF Production
  4. Packaging and Labeling
  5. Quality Control and Regulatory Compliance
  6. Distribution to Pharmaceutical Sponsors

Conclusion

The global Contract Pharmaceutical Manufacturing market is positioned for sustained and resilient growth over the forecast period. Increasing pharmaceutical complexity, cost optimization pressures, and global supply chain diversification will continue to drive outsourcing demand. Companies offering integrated services, regulatory excellence, and global manufacturing footprints will be best positioned to capture long-term growth opportunities.

Explore more reports here-
https://chemreports.com/reports

Table of Contents

Global Contract Pharmaceutical Manufacturing Market Professional Survey Report
1 Industry Overview of Contract Pharmaceutical Manufacturing
    1.1 Definition and Specifications of Contract Pharmaceutical Manufacturing
        1.1.1 Definition of Contract Pharmaceutical Manufacturing
        1.1.2 Specifications of Contract Pharmaceutical Manufacturing
    1.2 Classification of Contract Pharmaceutical Manufacturing
        1.2.1 API
        1.2.2 FDF
    1.3 Applications of Contract Pharmaceutical Manufacturing
        1.3.1 Specialty/Midsize
        1.3.2 Generics
        1.3.3 Big Pharma
        1.3.4 Other
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 Europe
        1.4.3 China
        1.4.4 Japan
        1.4.5 Southeast Asia
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Contract Pharmaceutical Manufacturing
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Contract Pharmaceutical Manufacturing
    2.3 Manufacturing Process Analysis of Contract Pharmaceutical Manufacturing
    2.4 Industry Chain Structure of Contract Pharmaceutical Manufacturing

3 Technical Data and Manufacturing Plants Analysis of Contract Pharmaceutical Manufacturing
    3.1 Capacity and Commercial Production Date of Global Contract Pharmaceutical Manufacturing Major Manufacturers
    3.2 Manufacturing Plants Distribution of Global Contract Pharmaceutical Manufacturing Major Manufacturers
    3.3 R&D Status and Technology Source of Global Contract Pharmaceutical Manufacturing Major Manufacturers
    3.4 Raw Materials Sources Analysis of Global Contract Pharmaceutical Manufacturing Major Manufacturers

4 Global Contract Pharmaceutical Manufacturing Overall Market Overview
    4.1 2013-E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2013-E Global Contract Pharmaceutical Manufacturing Capacity and Growth Rate Analysis
        4.2.2 2017 Contract Pharmaceutical Manufacturing Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2013-E Global Contract Pharmaceutical Manufacturing Sales and Growth Rate Analysis
        4.3.2 2017 Contract Pharmaceutical Manufacturing Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2013-E Global Contract Pharmaceutical Manufacturing Sales Price
        4.4.2 2017 Contract Pharmaceutical Manufacturing Sales Price Analysis (Company Segment)

5 Contract Pharmaceutical Manufacturing Regional Market Analysis
    5.1 North America Contract Pharmaceutical Manufacturing Market Analysis
        5.1.1 North America Contract Pharmaceutical Manufacturing Market Overview
        5.1.2 North America 2013-E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2013-E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.1.4 North America 2017 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.2 Europe Contract Pharmaceutical Manufacturing Market Analysis
        5.2.1 Europe Contract Pharmaceutical Manufacturing Market Overview
        5.2.2 Europe 2013-E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 Europe 2013-E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.2.4 Europe 2017 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.3 China Contract Pharmaceutical Manufacturing Market Analysis
        5.3.1 China Contract Pharmaceutical Manufacturing Market Overview
        5.3.2 China 2013-E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 China 2013-E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.3.4 China 2017 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.4 Japan Contract Pharmaceutical Manufacturing Market Analysis
        5.4.1 Japan Contract Pharmaceutical Manufacturing Market Overview
        5.4.2 Japan 2013-E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Japan 2013-E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.4.4 Japan 2017 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.5 Southeast Asia Contract Pharmaceutical Manufacturing Market Analysis
        5.5.1 Southeast Asia Contract Pharmaceutical Manufacturing Market Overview
        5.5.2 Southeast Asia 2013-E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Southeast Asia 2013-E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.5.4 Southeast Asia 2017 Contract Pharmaceutical Manufacturing Market Share Analysis
    5.6 India Contract Pharmaceutical Manufacturing Market Analysis
        5.6.1 India Contract Pharmaceutical Manufacturing Market Overview
        5.6.2 India 2013-E Contract Pharmaceutical Manufacturing Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2013-E Contract Pharmaceutical Manufacturing Sales Price Analysis
        5.6.4 India 2017 Contract Pharmaceutical Manufacturing Market Share Analysis

6 Global 2013-E Contract Pharmaceutical Manufacturing Segment Market Analysis (by Type)
    6.1 Global 2013-E Contract Pharmaceutical Manufacturing Sales by Type
    6.2 Different Types of Contract Pharmaceutical Manufacturing Product Interview Price Analysis
    6.3 Different Types of Contract Pharmaceutical Manufacturing Product Driving Factors Analysis
        6.3.1 API Growth Driving Factor Analysis
        6.3.2 FDF Growth Driving Factor Analysis

7 Global 2013-E Contract Pharmaceutical Manufacturing Segment Market Analysis (by Application)
    7.1 Global 2013-E Contract Pharmaceutical Manufacturing Consumption by Application
    7.2 Different Application of Contract Pharmaceutical Manufacturing Product Interview Price Analysis
    7.3 Different Application of Contract Pharmaceutical Manufacturing Product Driving Factors Analysis
        7.3.1 Specialty/Midsize of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis
        7.3.2 Generics of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis
        7.3.3 Big Pharma of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis
        7.3.4 Other of Contract Pharmaceutical Manufacturing Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Contract Pharmaceutical Manufacturing
    8.1 Catalent
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Catalent 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Catalent 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.2 DPx
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 DPx 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 DPx 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.3 Lonza
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Lonza 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Lonza 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.4 Piramal Healthcare
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Piramal Healthcare 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Piramal Healthcare 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.5 Aenova
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Aenova 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Aenova 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.6 Jubilant
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Jubilant 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Jubilant 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.7 Famar
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Famar 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Famar 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.8 Boehringer Ingelheim
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Boehringer Ingelheim 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Boehringer Ingelheim 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.9 Fareva Holding
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Fareva Holding 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Fareva Holding 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.10 AbbVie
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 AbbVie 2017 Contract Pharmaceutical Manufacturing Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 AbbVie 2017 Contract Pharmaceutical Manufacturing Business Region Distribution Analysis
    8.11 Nipro Corp
    8.12 Vetter
    8.13 Sopharma
    8.14 DPT Laboratories
    8.15 Recipharm
    8.16 NextPharma
    8.17 Dishman
    8.18 Aesica

9 Development Trend of Analysis of Contract Pharmaceutical Manufacturing Market
    9.1 Global Contract Pharmaceutical Manufacturing Market Trend Analysis
        9.1.1 Global -2025 Contract Pharmaceutical Manufacturing Market Size (Volume and Value) Forecast
        9.1.2 Global -2025 Contract Pharmaceutical Manufacturing Sales Price Forecast
    9.2 Contract Pharmaceutical Manufacturing Regional Market Trend
        9.2.1 North America -2025 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.2 Europe -2025 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.3 China -2025 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.4 Japan -2025 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.5 Southeast Asia -2025 Contract Pharmaceutical Manufacturing Consumption Forecast
        9.2.6 India -2025 Contract Pharmaceutical Manufacturing Consumption Forecast
    9.3 Contract Pharmaceutical Manufacturing Market Trend (Product Type)
    9.4 Contract Pharmaceutical Manufacturing Market Trend (Application)

10 Contract Pharmaceutical Manufacturing Marketing Type Analysis
    10.1 Contract Pharmaceutical Manufacturing Regional Marketing Type Analysis
    10.2 Contract Pharmaceutical Manufacturing International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Contract Pharmaceutical Manufacturing by Region
    10.4 Contract Pharmaceutical Manufacturing Supply Chain Analysis

11 Consumers Analysis of Contract Pharmaceutical Manufacturing
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Contract Pharmaceutical Manufacturing Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source
List of Tables and Figures
    Figure Picture of Contract Pharmaceutical Manufacturing
    Table Product Specifications of Contract Pharmaceutical Manufacturing
    Table Classification of Contract Pharmaceutical Manufacturing
    Figure Global Production Market Share of Contract Pharmaceutical Manufacturing by Type
    Figure API Picture
    Table Major Manufacturers of API
    Figure FDF Picture
    Table Major Manufacturers of FDF
    Table Applications of Contract Pharmaceutical Manufacturing
    Figure Global Consumption Volume Market Share of Contract Pharmaceutical Manufacturing by Application
    Figure Specialty/Midsize Examples
    Table Major Consumers in Specialty/Midsize
    Figure Generics Examples
    Table Major Consumers in Generics
    Figure Big Pharma Examples
    Table Major Consumers in Big Pharma
    Figure Other Examples
    Table Major Consumers in Other
    Figure Market Share of Contract Pharmaceutical Manufacturing by Regions
    Figure North America Contract Pharmaceutical Manufacturing Market Size (Million USD) (2013-2025)
    Figure Europe Contract Pharmaceutical Manufacturing Market Size (Million USD) (2013-2025)
    Figure China Contract Pharmaceutical Manufacturing Market Size (Million USD) (2013-2025)
    Figure Japan Contract Pharmaceutical Manufacturing Market Size (Million USD) (2013-2025)
    Figure Southeast Asia Contract Pharmaceutical Manufacturing Market Size (Million USD) (2013-2025)
    Figure India Contract Pharmaceutical Manufacturing Market Size (Million USD) (2013-2025)
    Table Contract Pharmaceutical Manufacturing Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Contract Pharmaceutical Manufacturing
    Figure Manufacturing Process Analysis of Contract Pharmaceutical Manufacturing
    Figure Industry Chain Structure of Contract Pharmaceutical Manufacturing
    Table Capacity and Commercial Production Date of Global Contract Pharmaceutical Manufacturing Major Manufacturers
    Table Manufacturing Plants Distribution of Global Contract Pharmaceutical Manufacturing Major Manufacturers
    Table R&D Status and Technology Source of Global Contract Pharmaceutical Manufacturing Major Manufacturers
    Table Raw Materials Sources Analysis of Global Contract Pharmaceutical Manufacturing Major Manufacturers
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Contract Pharmaceutical Manufacturing 2013-E
    Figure Global 2013-E Contract Pharmaceutical Manufacturing Market Size (Volume) and Growth Rate
    Figure Global 2013-E Contract Pharmaceutical Manufacturing Market Size (Value) and Growth Rate
    Table 2013-E Global Contract Pharmaceutical Manufacturing Capacity and Growth Rate
    Table 2017 Global Contract Pharmaceutical Manufacturing Capacity (K Units) List (Company Segment)
    Table 2013-E Global Contract Pharmaceutical Manufacturing Sales (K Units) and Growth Rate
    Table 2017 Global Contract Pharmaceutical Manufacturing Sales (K Units) List (Company Segment)
    Table 2013-E Global Contract Pharmaceutical Manufacturing Sales Price (USD/Unit)
    Table 2017 Global Contract Pharmaceutical Manufacturing Sales Price (USD/Unit) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Units) of Contract Pharmaceutical Manufacturing 2013-E
    Figure North America 2013-E Contract Pharmaceutical Manufacturing Sales Price (USD/Unit)
    Figure North America 2017 Contract Pharmaceutical Manufacturing Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Units) of Contract Pharmaceutical Manufacturing 2013-E
    Figure Europe 2013-E Contract Pharmaceutical Manufacturing Sales Price (USD/Unit)
    Figure Europe 2017 Contract Pharmaceutical Manufacturing Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Units) of Contract Pharmaceutical Manufacturing 2013-E
    Figure China 2013-E Contract Pharmaceutical Manufacturing Sales Price (USD/Unit)
    Figure China 2017 Contract Pharmaceutical Manufacturing Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Units) of Contract Pharmaceutical Manufacturing 2013-E
    Figure Japan 2013-E Contract Pharmaceutical Manufacturing Sales Price (USD/Unit)
    Figure Japan 2017 Contract Pharmaceutical Manufacturing Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Contract Pharmaceutical Manufacturing 2013-E
    Figure Southeast Asia 2013-E Contract Pharmaceutical Manufacturing Sales Price (USD/Unit)
    Figure Southeast Asia 2017 Contract Pharmaceutical Manufacturing Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Units) of Contract Pharmaceutical Manufacturing 2013-E
    Figure India 2013-E Contract Pharmaceutical Manufacturing Sales Price (USD/Unit)
    Figure India 2017 Contract Pharmaceutical Manufacturing Sales Market Share
    Table Global 2013-E Contract Pharmaceutical Manufacturing Sales (K Units) by Type
    Table Different Types Contract Pharmaceutical Manufacturing Product Interview Price
    Table Global 2013-E Contract Pharmaceutical Manufacturing Sales (K Units) by Application
    Table Different Application Contract Pharmaceutical Manufacturing Product Interview Price
    Table Catalent Information List
    Table Product Overview
    Table 2017 Catalent Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Catalent Contract Pharmaceutical Manufacturing Business Region Distribution
    Table DPx Information List
    Table Product Overview
    Table 2017 DPx Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 DPx Contract Pharmaceutical Manufacturing Business Region Distribution
    Table Lonza Information List
    Table Product Overview
    Table 2017 Lonza Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Lonza Contract Pharmaceutical Manufacturing Business Region Distribution
    Table Piramal Healthcare Information List
    Table Product Overview
    Table 2017 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Piramal Healthcare Contract Pharmaceutical Manufacturing Business Region Distribution
    Table Aenova Information List
    Table Product Overview
    Table 2017 Aenova Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Aenova Contract Pharmaceutical Manufacturing Business Region Distribution
    Table Jubilant Information List
    Table Product Overview
    Table 2017 Jubilant Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Jubilant Contract Pharmaceutical Manufacturing Business Region Distribution
    Table Famar Information List
    Table Product Overview
    Table 2017 Famar Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Famar Contract Pharmaceutical Manufacturing Business Region Distribution
    Table Boehringer Ingelheim Information List
    Table Product Overview
    Table 2017 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Business Region Distribution
    Table Fareva Holding Information List
    Table Product Overview
    Table 2017 Fareva Holding Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Fareva Holding Contract Pharmaceutical Manufacturing Business Region Distribution
    Table AbbVie Information List
    Table Product Overview
    Table 2017 AbbVie Contract Pharmaceutical Manufacturing Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 AbbVie Contract Pharmaceutical Manufacturing Business Region Distribution
    Table Nipro Corp Information List
    Table Vetter Information List
    Table Sopharma Information List
    Table DPT Laboratories Information List
    Table Recipharm Information List
    Table NextPharma Information List
    Table Dishman Information List
    Table Aesica Information List
    Figure Global -2025 Contract Pharmaceutical Manufacturing Market Size (K Units) and Growth Rate Forecast
    Figure Global -2025 Contract Pharmaceutical Manufacturing Market Size (Million USD) and Growth Rate Forecast
    Figure Global -2025 Contract Pharmaceutical Manufacturing Sales Price (USD/Unit) Forecast
    Figure North America -2025 Contract Pharmaceutical Manufacturing Consumption Volume (K Units) and Growth Rate Forecast
    Figure China -2025 Contract Pharmaceutical Manufacturing Consumption Volume (K Units) and Growth Rate Forecast
    Figure Europe -2025 Contract Pharmaceutical Manufacturing Consumption Volume (K Units) and Growth Rate Forecast
    Figure Southeast Asia -2025 Contract Pharmaceutical Manufacturing Consumption Volume (K Units) and Growth Rate Forecast
    Figure Japan -2025 Contract Pharmaceutical Manufacturing Consumption Volume (K Units) and Growth Rate Forecast
    Figure India -2025 Contract Pharmaceutical Manufacturing Consumption Volume (K Units) and Growth Rate Forecast
    Table Global Sales Volume (K Units) of Contract Pharmaceutical Manufacturing by Type -2025
    Table Global Consumption Volume (K Units) of Contract Pharmaceutical Manufacturing by Application -2025
    Table Traders or Distributors with Contact Information of Contract Pharmaceutical Manufacturing by Region

Market Segmentation

By Product Type

1. Active Pharmaceutical Ingredients (API)

  • Small molecule APIs
  • High-potency APIs (HPAPI)
  • Specialty and complex chemical APIs
    API manufacturing represents a significant revenue share due to high technical complexity, regulatory burden, and increasing outsourcing by innovator and generic companies.

2. Finished Dosage Form (FDF)

  • Solid oral dosage forms
  • Injectables
  • Semi-solids and liquids
    FDF outsourcing is expanding rapidly, driven by demand for scalable production, sterile manufacturing capabilities, and lifecycle management services.

By Application

  • Big Pharma
    Focus on large-scale production, global supply reliability, and regulatory compliance
  • Generics
    High-volume, cost-efficient manufacturing with rapid market entry requirements
  • Specialty and Mid-sized Pharmaceutical Companies
    Outsourcing driven by limited internal manufacturing infrastructure
  • Other Applications
    Includes biotech firms, virtual pharma companies, and contract development projects

Key Market Players

  • Catalent
  • DPx
  • Lonza
  • Piramal Healthcare
  • Aenova
  • Jubilant
  • Famar
  • Boehringer Ingelheim
  • Fareva Holding
  • AbbVie
  • Nipro Corp
  • Vetter
  • Sopharma
  • DPT Laboratories
  • Recipharm
  • NextPharma
  • Dishman
  • Aesica

Competitive strategies include capacity expansion, geographic diversification, biologics capability enhancement, and mergers and acquisitions.

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.